Home / Health / Daughter's Usher Syndrome Sparks Hope for Sight Therapies
Daughter's Usher Syndrome Sparks Hope for Sight Therapies
15 Nov
Summary
- Poppy has Usher syndrome type 2A, causing progressive vision loss.
- New RNA-editing platform EDITRA aims to fix genetic spelling mistakes.
- Researchers in Melbourne are developing potential treatments for vision loss.
Poppy, a five-year-old girl, has been diagnosed with Usher syndrome type 2A, a rare inherited condition causing progressive vision loss. This diagnosis means she will likely experience deteriorating eyesight throughout her life, impacting her independence and choices.
Her parents, initially navigating the challenges of her hearing loss, received the Usher syndrome diagnosis during the COVID-19 pandemic. This news reshaped their family planning and prompted them to seek support and understanding.
Usher syndrome type 2A affects approximately 1 in 6,000 children in Australia, leading to acquired deafblindness. While night vision problems typically begin in adolescence, the progression varies among individuals.
In Melbourne, researchers at the Centre for Eye Research Australia (CERA) are making strides. They are developing a novel RNA-editing platform, EDITRA, designed to correct the genetic spelling mistakes responsible for vision loss in Usher syndrome.
This innovative treatment, still in the laboratory phase, offers a potential pathway to help children like Poppy retain their sight. The development mirrors past successes in medical research, such as the cochlear implant, instilling hope for future breakthroughs.
